Connection
Janet Rader to Phosphatidylinositol 3-Kinases
This is a "connection" page, showing publications Janet Rader has written about Phosphatidylinositol 3-Kinases.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.122 |
|
|
|
-
Schwarz JK, Payton JE, Rashmi R, Xiang T, Jia Y, Huettner P, Rogers BE, Yang Q, Watson M, Rader JS, Grigsby PW. Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer. Clin Cancer Res. 2012 Mar 01; 18(5):1464-71.
Score: 0.094
-
Rashmi R, DeSelm C, Helms C, Bowcock A, Rogers BE, Rader JL, Rader J, Grigsby PW, Schwarz JK. AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake. PLoS One. 2014; 9(4):e92948.
Score: 0.028